Tumor-Resident Microbes and Small Molecular Anti-Cancer Drugs in Tumor Microenvironment
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: closed (30 June 2024) | Viewed by 400
Special Issue Editor
Special Issue Information
Dear Colleagues,
The tumor-resident microbiota and some small molecular anti-cancer drugs are associated with the development and progression of cancer, and manipulation of the tumor-resident microbiota is a novel strategy for the prevention and treatment of cancer. Some microbita have antitumor activity against cancer, improving the tumor microenvironment, activating immune cells including dendritic cells, helper T cells, natural killer cells, and cytotoxic T cells, and upregulating the secretion of pro-tumor immune cytokines such as interleukin-2 and interferon. Tumor-resident microbiota and some metabolites are involved in anticancer drug design and targeted delivery.
Dr. Chenglai Xia
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- tumor-resident microbiota
- immune checkpoint inhibitors
- microbiota metabolites
- anticancer drug design
- drug targeted delivery
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
